Terms: = Skin cancer AND PPP6C, O00743, 5537, ENSG00000119414
14 results:
1. Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma.
Shi F; Zhang W; Yang Y; Yang Y; Zhao J; Xie M; Sheng C; Wang S; Wang Q
Front Immunol; 2021; 12():721409. PubMed ID: 34795662
[TBL] [Abstract] [Full Text] [Related]
2. ppp6c haploinsufficiency accelerates UV-induced BRAF(V600E)-initiated melanomagenesis.
Kanazawa K; Kishimoto K; Nomura M; Kurosawa K; Kato H; Inoue Y; Miura K; Fukui K; Yamashita Y; Sato I; Tsuji H; Watanabe T; Tanaka T; Yasuda J; Tanuma N; Shima H
Cancer Sci; 2021 Jun; 112(6):2233-2244. PubMed ID: 33743547
[TBL] [Abstract] [Full Text] [Related]
3. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
4. Detection of driver mutations in FFPE samples from patients with verified malignant melanoma.
Malicherova B; Burjanivova T; Minarikova E; Kasubova I; Pecova T; Bobrovska M; Homola I; Lasabova Z; Plank L
Neoplasma; 2019 Jan; 66(1):33-38. PubMed ID: 30509087
[TBL] [Abstract] [Full Text] [Related]
5. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.
Bonilla X; Parmentier L; King B; Bezrukov F; Kaya G; Zoete V; Seplyarskiy VB; Sharpe HJ; McKee T; Letourneau A; Ribaux PG; Popadin K; Basset-Seguin N; Ben Chaabene R; Santoni FA; Andrianova MA; Guipponi M; Garieri M; Verdan C; Grosdemange K; Sumara O; Eilers M; Aifantis I; Michielin O; de Sauvage FJ; Antonarakis SE; Nikolaev SI
Nat Genet; 2016 Apr; 48(4):398-406. PubMed ID: 26950094
[TBL] [Abstract] [Full Text] [Related]
6. Mutational status of naevus-associated melanomas.
Shitara D; Tell-Martí G; Badenas C; Enokihara MM; Alós L; Larque AB; Michalany N; Puig-Butille JA; Carrera C; Malvehy J; Puig S; Bagatin E
Br J Dermatol; 2015 Sep; 173(3):671-80. PubMed ID: 25857817
[TBL] [Abstract] [Full Text] [Related]
7. A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
Xia J; Jia P; Hutchinson KE; Dahlman KB; Johnson D; Sosman J; Pao W; Zhao Z
Mol Cancer Ther; 2014 Jul; 13(7):1918-28. PubMed ID: 24755198
[TBL] [Abstract] [Full Text] [Related]
8. [Ultraviolet A-induced DNA damage: role in skin cancer].
Beani JC
Bull Acad Natl Med; 2014 Feb; 198(2):273-95. PubMed ID: 26263704
[TBL] [Abstract] [Full Text] [Related]
9. [Melanoma: from molecular studies to the treatment breakthrough].
Imianitov EN
Arkh Patol; 2013; 75(5):63-72. PubMed ID: 24341237
[TBL] [Abstract] [Full Text] [Related]
10. PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition.
Gold HL; Wengrod J; de Miera EV; Wang D; Fleming N; Sikkema L; Kirchhoff T; Hochman T; Goldberg JD; Osman I; Gardner LB
Mol Cancer Res; 2014 Mar; 12(3):433-9. PubMed ID: 24336958
[TBL] [Abstract] [Full Text] [Related]
11. Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A.
Hammond D; Zeng K; Espert A; Bastos RN; Baron RD; Gruneberg U; Barr FA
J Cell Sci; 2013 Aug; 126(Pt 15):3429-40. PubMed ID: 23729733
[TBL] [Abstract] [Full Text] [Related]
12. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
Krauthammer M; Kong Y; Ha BH; Evans P; Bacchiocchi A; McCusker JP; Cheng E; Davis MJ; Goh G; Choi M; Ariyan S; Narayan D; Dutton-Regester K; Capatana A; Holman EC; Bosenberg M; Sznol M; Kluger HM; Brash DE; Stern DF; Materin MA; Lo RS; Mane S; Ma S; Kidd KK; Hayward NK; Lifton RP; Schlessinger J; Boggon TJ; Halaban R
Nat Genet; 2012 Sep; 44(9):1006-14. PubMed ID: 22842228
[TBL] [Abstract] [Full Text] [Related]
13. A landscape of driver mutations in melanoma.
Hodis E; Watson IR; Kryukov GV; Arold ST; Imielinski M; Theurillat JP; Nickerson E; Auclair D; Li L; Place C; Dicara D; Ramos AH; Lawrence MS; Cibulskis K; Sivachenko A; Voet D; Saksena G; Stransky N; Onofrio RC; Winckler W; Ardlie K; Wagle N; Wargo J; Chong K; Morton DL; Stemke-Hale K; Chen G; Noble M; Meyerson M; Ladbury JE; Davies MA; Gershenwald JE; Wagner SN; Hoon DS; Schadendorf D; Lander ES; Gabriel SB; Getz G; Garraway LA; Chin L
Cell; 2012 Jul; 150(2):251-63. PubMed ID: 22817889
[TBL] [Abstract] [Full Text] [Related]
14. Cost of nonmelanoma skin cancer treatment in the United States.
Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
[TBL] [Abstract] [Full Text] [Related]
